Summary: CVS Caremark Corp. - S&P Global Ratings’ Credit Research

Summary: CVS Caremark Corp.

Summary: CVS Caremark Corp. - S&P Global Ratings’ Credit Research
Summary: CVS Caremark Corp.
Published Jun 21, 2013
1860 words — Published Jun 21, 2013
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

Strong competitive position as the largest integrated pharmacy company in the favorably regarded U.S. drugstore industry; Unique integrated model combining retail and mail order enhances access and differentiates the company from standalone drugstores or pharmacy benefit managers (PBMs); and Consistent and solid sales and earnings growth. Commitment to maintain current debt leverage target; Diverse cash flow stream from retail and PBM; Strong free cash flow generation; and Substantial share repurchase program and dividend payout, consuming most of its free cash flow. The stable rating outlook on CVS Caremark Corp. reflects our expectations that credit measures will improve modestly in 2013, given improving profitability from a strong generic drug pipeline and healthy sales growth. The rating also reflects our view that

  
Brief Excerpt:

RESEARCH Summary: CVS Caremark Corp. Publication date: 21-Jun-2013 Primary Credit Analyst: Ana Lai, CFA, New York (1) 212-438-6895; ana.lai@standardandpoors.com Secondary Contact: Mariola Borysiak, New York (1) 212-438-7839; mariola.borysiak@standardand...

  
Report Type:

Summary

Ticker
CVS
Issuer
CVS Health Corp.
GICS
Health Care Services (35102015)
Sector
Global Issuers , Structured Finance
Country
United States
Region
United States
Format:
PDF Adobe Acrobat
Buy Now

Summary: CVS Caremark Corp. – 2014/03/20 – US$ 225.00

Summary: CVS Health Corp. – 2014/09/04 – US$ 225.00

Summary: CVS Caremark Corp. – 2012/12/11 – US$ 225.00

CVS Caremark Corp. – 2012/06/27 – US$ 500.00

Summary: CVS Caremark Corp. – 2012/06/27 – US$ 225.00

Summary: CVS Caremark Corp. – 2011/12/22 – US$ 225.00

Summary: CVS Caremark Corp. – 2011/06/29 – US$ 225.00

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Summary: CVS Caremark Corp." Jun 21, 2013. Alacra Store. May 05, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Summary-CVS-Caremark-Corp-1149632>
  
APA:
S&P Global Ratings’ Credit Research. (). Summary: CVS Caremark Corp. Jun 21, 2013. New York, NY: Alacra Store. Retrieved May 05, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Summary-CVS-Caremark-Corp-1149632>
  
US$ 225.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.